Evidence map›Paper›PMID 32804084›Full record

ArticleJMIR cancer2020

Incorporating Breast Cancer Recurrence Events Into Population-Based Cancer Registries Using Medical Claims: Cohort Study.

Teresa A'mar, J David Beatty, Catherine Fedorenko, Daniel Markowitz, Thomas Corey, Jane Lange, Stephen M Schwartz, Bin Huang, Jessica Chubak, Ruth Etzioni

Erratum issuedAbstract read
In one paragraph

Article in JMIR cancer, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Identifying breast cancer recurrence histories via patient-reported outcomes.Journal of cancer survivorship : research and practice · 2022
    Article
  6. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

10 authors.

Teresa A'mar *Public Health Sciences, Fred Hutchinson Cancer Research Center, Seattle, WA, United States.ORCID https://orcid.org/0000-0002-8634-1142
J David BeattySwedish Cancer Institute, Seattle, WA, United States.ORCID https://orcid.org/0000-0001-9693-6812
Catherine FedorenkoPublic Health Sciences, Fred Hutchinson Cancer Research Center, Seattle, WA, United States.ORCID https://orcid.org/0000-0002-6478-0769
Daniel MarkowitzSwedish Cancer Institute, Seattle, WA, United States.ORCID https://orcid.org/0000-0002-0841-844X
Thomas CoreyPublic Health Sciences, Fred Hutchinson Cancer Research Center, Seattle, WA, United States.ORCID https://orcid.org/0000-0003-3044-2072
Jane LangePublic Health Sciences, Fred Hutchinson Cancer Research Center, Seattle, WA, United States.ORCID https://orcid.org/0000-0002-0014-9679
Stephen M SchwartzPublic Health Sciences, Fred Hutchinson Cancer Research Center, Seattle, WA, United States.ORCID https://orcid.org/0000-0001-7499-8502
Bin HuangCollege of Medicine, University of Kentucky, Lexington, KY, United States.ORCID https://orcid.org/0000-0002-9075-1531
Jessica Chubak *Kaiser Permanente Washington Health Research Institute, Seattle, WA, United States.ORCID https://orcid.org/0000-0003-1630-9021
Ruth Etzioni *Public Health Sciences, Fred Hutchinson Cancer Research Center, Seattle, WA, United States.ORCID https://orcid.org/0000-0002-9164-6370

Funding

Long-term Survivorship in Older Women with Early Stage Breast CancerR01CA093772 · NCI · BOSTON MEDICAL CENTER · PI SILLIMAN, REBECCA A · 2003 to 2011
$7.5M
Commonly Used Medications and Breast Cancer RecurrenceR01CA120562 · NCI · KAISER FOUNDATION HEALTH PLAN OF WASHINGTON · PI BOUDREAU, DENISE M · 2007 to 2011
$2.1M
ReCAPSE: Recurrence from Claims And PROs for SEER EnhancementUH3CA218909 · NCI · FRED HUTCHINSON CANCER RESEARCH CENTER · PI CHUBAK, JESSICA, ETZIONI, RUTH D · 2020 to 2022
$1.7M
ReCAPSE: Recurrence from Claims And PROs for SEER EnhancementUG3CA218909 · NCI · FRED HUTCHINSON CANCER RESEARCH CENTER · PI CHUBAK, JESSICA, ETZIONI, RUTH D · 2017 to 2018
$900k
Algorithms to Identify Second Breast Cancer Events from Electronic DataR21CA143242 · NCI · KAISER FOUNDATION HEALTH PLAN OF WASHINGTON · PI CHUBAK, JESSICA · 2010 to 2011
$377k
SURVEILLANCE EPIDEMIOLOGY &END RESULTS PROGRAMN01CN067009 · CN · FRED HUTCHINSON CANCER RESEARCH CENTER · PI THOMAS, DAVID B · 1996 to 1997
–
NCI NIH HHS N01 CN067009NCI NIH HHS N01 PC035142NCI NIH HHS R01 CA093772NCI NIH HHS R01 CA120562NCI NIH HHS R21 CA143242NCI NIH HHS UG3 CA218909NCI NIH HHS UH3 CA218909
6 · The paper itself

Abstract

backgroundThere is a need for automated approaches to incorporate information on cancer recurrence events into population-based cancer registries.

objectiveThe aim of this study is to determine the accuracy of a novel data mining algorithm to extract information from linked registry and medical claims data on the occurrence and timing of second breast cancer events (SBCE).

methodsWe used supervised data from 3092 stage I and II breast cancer cases (with 394 recurrences), diagnosed between 1993 and 2006 inclusive, of patients at Kaiser Permanente Washington and cases in the Puget Sound Cancer Surveillance System. Our goal was to classify each month after primary treatment as pre- versus post-SBCE. The prediction feature set for a given month consisted of registry variables on disease and patient characteristics related to the primary breast cancer event, as well as features based on monthly counts of diagnosis and procedure codes for the current, prior, and future months. A month was classified as post-SBCE if the predicted probability exceeded a probability threshold (PT); the predicted time of the SBCE was taken to be the month of maximum increase in the predicted probability between adjacent months.

resultsThe Kaplan-Meier net probability of SBCE was 0.25 at 14 years. The month-level receiver operating characteristic curve on test data (20% of the data set) had an area under the curve of 0.986. The person-level predictions (at a monthly PT of 0.5) had a sensitivity of 0.89, a specificity of 0.98, a positive predictive value of 0.85, and a negative predictive value of 0.98. The corresponding median difference between the observed and predicted months of recurrence was 0 and the mean difference was 0.04 months.

conclusionsData mining of medical claims holds promise for the streamlining of cancer registry operations to feasibly collect information about second breast cancer events.

Indexed as

breast cancercancer recurrence eventcancer registriesdata miningmedical claimsmedical informaticsstatistical learning

Identifiers

PMID32804084
PMCPMC7459434

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.